NCT07326423Enrolling by invitation
Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With Autism
Mental Imagery Therapy for Autism (MITA) - a Randomized Controlled Study of Early Intervention Computerized Brain Training Program for Children With ASD
Source: ClinicalTrials.gov · Last updated 8 Jan 2026
Brief summary (registry, in English)
Mental Imagery Therapy for Autism (MITA) is a highly innovative adaptive language therapy application for children with autism. MITA exercises are limitless in variations, therefore avoiding routinization. Each activity is dynamic, quickly adjusting to the child's exact ability level. All activities are disguised as games that engage children. A 3-year observational clinical study of 6,454 children with ASD demonstrated that children who engaged with MITA showed 2.2-fold greater language improvement than children with similar initial evaluations (p\<0.0001). This study explores MITA intervention in a randomized controlled trial of 60 children with ASD. Two- to five-year-old ASD children will be randomly assigned to one of two groups. The MITA group will supplement their conventional language therapy with MITA exercises. The control group will receive treatment-as-usual. The hypothesis is that the MITA group will show greater improvement in developmental milestones.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 19 Dec 2025
- Start date
- Sept 2021
- Primary completion date
- Dec 2026
- Lead sponsor
- ImagiRation, LLC
- Diseases
- Autism
- NCT number
- NCT07326423
What you commit to
- Study type: Interventional
- Planned participants: 60
- From Sept 2021 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- use of psychoactive medications,
- alcohol or drug exposure during the prenatal period,
Other illness
- a neurodevelopmental disorder of known etiology (e.g., fragile X syndrome)
- significant sensory or motor impairment,
- major physical problems such as a chronic serious health condition,
- seizures at time of entry. Children who developed seizures during the course of the study were not excluded.
- history of a serious head injury and/or neurologic disease,
Other
- CARS-2 total score \> 48 (severe ASD).
Who the study is looking for
- age 2 and 5 years at the time of enrollment
- diagnosis of ASD confirmed by a study investigator who was experienced in ASD diagnosis.
Age in the registry: 2 years to 5 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Espacosomare Coordinator of this site? Confirm its status | Foz do Iguaçu | Brazil | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.